The observation that Id-specific TCR-transgenic mice were more resistant to myeloma in the absence than in the presence of SH2D2A could be due to altered vascular function, as SH2D2A is also expressed in endothelial cells [31], [32]. This evidence concerns the gene ID1 and plasma cell myeloma.